Soy Protein Formulas in Children: No Hormonal Effects in Long-term Feeding

  title={Soy Protein Formulas in Children: No Hormonal Effects in Long-term Feeding},
  author={Paolo G Giampietro and G. Bruno and Giuseppe Furcolo and Alessio Casati and Ercole Brunetti and Gian Luigi Spadoni and Elena Galli},
  journal={Journal of Pediatric Endocrinology and Metabolism},
  pages={191 - 196}
Recently, the finding of high plasma concentration of phyto-oestrogens in soy protein formula (SPF) fed children has focused scientific attention on the phyto-oestrogens (isoflavones genistein, daidzein, and their glycosides) contained in SPFs. The aim of this study was to evaluate some hormonal and metabolic effects of long-term (more than 6 months) SPF feeding. We enrolled 48 children, mean age 37 months (range 7-96 months), 27 males and 21 females. All children underwent physical examination… 

Figures and Tables from this paper

Consumption of soy-based infant formula is not associated with early onset of puberty

This is the first prospective, physical examination-based study, demonstrating no association between infantile soy-based formula consumption and growth and puberty parameters.

Safety of soya-based infant formulas in children

Modern SIF are evidence-based safety options to feed children requiring them and the patterns of growth, bone health and metabolic, reproductive, endocrine, immune and neurological functions are similar to those observed in children fed CMF or HM.

Effects of soy-based formula on infants' growth and blood laboratory values spanning 3 years after birth

At 5 months of age, body weight was the lowest in the SF group; the height was similar among all groups; there were no differences in height or weight among the groups until 36 years of age.

The effects of soybean isoflavones over the bone health of adult and children

The aim of this research is to present a systematic review of the soy isoflavone chemistry and their effects on bone health in adults and children.

Choice of Foods and Ingredients for Moderately Malnourished Children 6 Months to 5 Years of Age

An overview of the nutritional qualities of relevant foods and ingredients in relation to the nutritional needs of children with moderate malnutrition is given and research needs are identified to identify research needs.

13. Soy protein infant formula in infant nutrition

In the treatment of cow’s milk protein allergy (CMPA), SIF is mainly used, preferably after the age of 6 months, for economic reasons or if infants refuse to drink bitter tasting extensive hydrolysates and is better tolerated in infants with Immunoglobulin E (IgE) mediated CMPA.

Programming of Bone and Reproductive Health by Early Life Exposure to Soy Isoflavones and Folic Acid in CD-1 Mice

It is hypothesized that early life exposure to ISO was improving adult bone outcomes by altering expression of genes that modulate bone development, possibly via DNA methylation, and that providing a methyl donor such as folic acid to the maternal diet during pregnancy and lactation could enhance the positive effects of ISO.

Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review

The results of human studies on dietary phytoestrogens are summarized with the aim of assessing the possible hormone-dependent outcomes and health effects of their consumption throughout a lifespan, focusing on pregnancy, childhood, adulthood, and the premenopausal and postmenopausal stages.

Dietary isoflavones act on bone marrow osteoprogenitor cells and stimulate ovary development before influencing bone mass in pre‐pubertal piglets

It is concluded that dietary isoflavones have no detectable effect on the bone mass of growing female piglets, but act on bone marrow osteoprogenitors via ERs—mainly ERβ, and stimulate ovary development.

Soy-based infant nutrition: a review

Dietary consumption of soy varies worldwide. In Asia, people traditionally consume large quantities of soy, while in Europe, soy is not part of the traditional or daily eating habits. The USA is a



Exposure of infants to phyto-oestrogens from soy-based infant formula

Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood.

Exposure to soy formula does not appear to lead to different general health or reproductive outcomes than exposure to cow milk formula, and the findings are reassuring about the safety of infant soy formula.

Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life.

The high steady state plasma concentration of isoflavones in infants fed soy-based formula is explained by reduced intestinal biotransformation, as evidenced by low or undetectable concentrations of equol and other metabolites, and is maintained by constant daily exposure from frequent feeding.

Soy-based formulae and infant growth and development: a review.

Results suggest that modern soy-based formulae support normal growth and nutritional status in healthy term infants in the first year of life, but there are very limited data on sexual and reproductive development or outcomes such as immune function, visual acuity/cognitive development and thyroid function.

The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women.

The difference in total- and LDL-cholesterol lowering between the 2 soy-protein supplements suggests an effect attributable to the isoflavone-containing fraction, however, the unexpected LDL-Cholesterol lowering observed in the Milk group, and the fact that there was no significant difference between either soy group and the milk group, suggests that changes may have been due to other factors related to participation in the study.

Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin.

It is suggested that the preventive effect of daidzin or glycitin on bone loss in ovx rats is due to suppression of bone turnover, as in the case of estrone, but genistin has a different mechanism of action from the other compounds.

Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas.

Values are similar to those for adults and indicate that young infants are able to digest, absorb, and excrete genistein and daidzein from soy-based formulas as efficiently as do adults consuming soy products.

Soy proteins and cardiovascular disease

Recent data suggest that soy protein subunits, particularly 7S, directly activiate LDL receptors in the human liver, thus providing a novel mechanism of plasma cholesterol reduction different from currently available diets and hypolipidemic drugs.

Effects of soy isoflavones on atherosclerosis: potential mechanisms.

It has long been recognized that coronary heart disease rates are lower in Japan, where soy consumption is common, than in Western countries. In experimental studies, atherosclerosis was reduced in

Decreased ovarian hormones during a soya diet: implications for breast cancer prevention.

It is suggested that at least under the conditions of this study, soya-induced reductions of circulating ovarian steroids are not mediated by gonadotropins, and may explain decreased ovarian hormone levels and decreased risk of breast cancer in populations consuming soya diets and have implications for reducing breast cancer risk by dietary intervention.